Dr. Kris on Integrating Driver Mutation Testing Study Results

Mark G. Kris, MD
Published: Friday, Jul 08, 2011



Lead author Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses adjusting practice to integrate the results from the multicenter study focusing on the identification of driver mutations in tumor specimens in patients with lung adenocarcinoma. This study was conducted as part of the American Recovery and Reinvestment act by the National Cancer Institutes' Lung Cancer Mutation Consortium (LCMC).
SELECTED
LANGUAGE


Lead author Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses adjusting practice to integrate the results from the multicenter study focusing on the identification of driver mutations in tumor specimens in patients with lung adenocarcinoma. This study was conducted as part of the American Recovery and Reinvestment act by the National Cancer Institutes' Lung Cancer Mutation Consortium (LCMC).

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Community Practice Connections™: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for NursesJun 29, 20191.5
Publication Bottom Border
Border Publication
x